217 related articles for article (PubMed ID: 29383855)
1. Therapeutic applications of group I intron-based trans-splicing ribozymes.
Lee CH; Han SR; Lee SW
Wiley Interdiscip Rev RNA; 2018 May; 9(3):e1466. PubMed ID: 29383855
[TBL] [Abstract][Full Text] [Related]
2. Group I Intron-Based Therapeutics Through Trans-Splicing Reaction.
Lee CH; Han SR; Lee SW
Prog Mol Biol Transl Sci; 2018; 159():79-100. PubMed ID: 30340790
[TBL] [Abstract][Full Text] [Related]
3. Trans-splicing with the group I intron ribozyme from Azoarcus.
Dolan GF; Müller UF
RNA; 2014 Feb; 20(2):202-13. PubMed ID: 24344321
[TBL] [Abstract][Full Text] [Related]
4. Ribozyme-mediated repair of defective mRNA by targeted, trans-splicing.
Sullenger BA; Cech TR
Nature; 1994 Oct; 371(6498):619-22. PubMed ID: 7935797
[TBL] [Abstract][Full Text] [Related]
5. RNA reprogramming of alpha-mannosidase mRNA sequences in vitro by myxomycete group IC1 and IE ribozymes.
Fiskaa T; Lundblad EW; Henriksen JR; Johansen SD; Einvik C
FEBS J; 2006 Jun; 273(12):2789-800. PubMed ID: 16817905
[TBL] [Abstract][Full Text] [Related]
6. Efficient and specific repair of sickle beta-globin RNA by trans-splicing ribozymes.
Byun J; Lan N; Long M; Sullenger BA
RNA; 2003 Oct; 9(10):1254-63. PubMed ID: 13130139
[TBL] [Abstract][Full Text] [Related]
7. RNA as a drug target: recent patents on the catalytic activity of trans-splicing ribozymes derived from group I intron RNA.
Johnson IM
Recent Pat DNA Gene Seq; 2010 Jan; 4(1):17-28. PubMed ID: 20218956
[TBL] [Abstract][Full Text] [Related]
8. Heterodimerization of Group I Ribozymes Enabling Exon Recombination through Pairs of Cooperative trans-Splicing Reactions.
Tanaka T; Hirata Y; Tominaga Y; Furuta H; Matsumura S; Ikawa Y
Chembiochem; 2017 Aug; 18(16):1659-1667. PubMed ID: 28556398
[TBL] [Abstract][Full Text] [Related]
9. Trans-splicing ribozymes for targeted gene delivery.
Köhler U; Ayre BG; Goodman HM; Haseloff J
J Mol Biol; 1999 Feb; 285(5):1935-50. PubMed ID: 9925776
[TBL] [Abstract][Full Text] [Related]
10. Ribozymes as therapeutic tools for genetic disease.
Phylactou LA; Kilpatrick MW; Wood MJ
Hum Mol Genet; 1998; 7(10):1649-53. PubMed ID: 9735387
[TBL] [Abstract][Full Text] [Related]
11. Modulating the splicing activity of Tetrahymena ribozyme via RNA self-assembly.
Hasegawa S; Rao J
FEBS Lett; 2006 Mar; 580(6):1592-6. PubMed ID: 16472807
[TBL] [Abstract][Full Text] [Related]
12. Drugs made of RNA: development and application of engineered RNAs for gene therapy.
Drude I; Dombos V; Vauléon S; Müller S
Mini Rev Med Chem; 2007 Sep; 7(9):912-31. PubMed ID: 17897081
[TBL] [Abstract][Full Text] [Related]
13. Design and Experimental Evolution of trans-Splicing Group I Intron Ribozymes.
Müller UF
Molecules; 2017 Jan; 22(1):. PubMed ID: 28045452
[TBL] [Abstract][Full Text] [Related]
14. Selective expression of transgene using hypoxia-inducible trans-splicing group I intron ribozyme.
Kim SJ; Lee SW
J Biotechnol; 2014 Dec; 192 Pt A():22-7. PubMed ID: 25312327
[TBL] [Abstract][Full Text] [Related]
15. Conditional and target-specific transgene induction through RNA replacement using an allosteric trans-splicing ribozyme.
Kim J; Jeong S; Kertsburg A; Soukup GA; Lee SW
ACS Chem Biol; 2014 Nov; 9(11):2491-5. PubMed ID: 25265474
[TBL] [Abstract][Full Text] [Related]
16. An in vivo selection method to optimize trans-splicing ribozymes.
Olson KE; Müller UF
RNA; 2012 Mar; 18(3):581-9. PubMed ID: 22274958
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic applications of ribozymes.
Kijima H; Ishida H; Ohkawa T; Kashani-Sabet M; Scanlon KJ
Pharmacol Ther; 1995; 68(2):247-67. PubMed ID: 8719970
[TBL] [Abstract][Full Text] [Related]
18. Specific and Efficient Regression of Cancers Harboring KRAS Mutation by Targeted RNA Replacement.
Kim SJ; Kim JH; Yang B; Jeong JS; Lee SW
Mol Ther; 2017 Feb; 25(2):356-367. PubMed ID: 28153088
[TBL] [Abstract][Full Text] [Related]
19. [Construction of a trans-splicing ribozyme for restoring EGFP truncation mutation].
Li B; Xiong YQ; Tu HB; Liu QC; Zou DT; Zhou WQ; Chen YY
Sheng Wu Gong Cheng Xue Bao; 2005 Sep; 21(5):748-53. PubMed ID: 16285516
[TBL] [Abstract][Full Text] [Related]
20. RNA reprogramming and repair based on trans-splicing group I ribozymes.
Fiskaa T; Birgisdottir AB
N Biotechnol; 2010 Jul; 27(3):194-203. PubMed ID: 20219714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
